Zr-MOF@PPA/AF@PEG take advantage of the PDT-induced hypoxia to activate HIF-1 inhibitor AF to enhance the anti-tumor effect and achieve the synergistic PDT- chemotherapy (PDT-CT) therapeutic effects. The gene discussed is HIF1A; the disease is neoplasm.